Go to the list of all blogs
Allana's Avatar
published in Blogs
Aug 04, 2026
Why Is Centuri Holdings (CTRI) Stock Down -17.52% Today?

Why Is Centuri Holdings (CTRI) Stock Down -17.52% Today?

Key Takeaways

  • Centuri Holdings shares plunged approximately 17.52% on Tuesday, falling from a previous close of $27.86 to around $22.98.
  • The sell-off came despite the company reporting record quarterly revenue of $962.0 million and raising full-year 2026 guidance.
  • Investors focused on margin compression, with base gross profit margin declining to 7.9% from 8.9% a year ago, driven by elevated fuel costs and labor ramp-up expenses.
  • A $9.0 million write-down of legacy City of Chicago receivables and a GAAP net income decline versus the prior year further weighed on sentiment.
  • JPMorgan lowered its price target on CTRI from $29 to $26 following the report.
  • Traders are now watching whether the second-half margin recovery management projected — targeting approximately 9.0% base gross profit margin — materializes.

Opening Summary

Centuri Holdings, Inc. (CTRI), a Phoenix-based utility infrastructure services company that builds and maintains energy networks across the United States and Canada, saw its stock plummet roughly 17.52% on Tuesday. Shares closed the prior session at $27.86 and fell to approximately $22.98 in the wake of the company's second-quarter 2026 earnings release. The sharp decline came despite headline numbers that surpassed certain consensus estimates, as margin pressures, one-time charges, and a pattern of post-earnings sell-offs dating back to the first quarter rattled investor confidence.

Earnings Beat Overshadowed by Margin Compression

On the surface, Centuri's Q2 2026 results appeared strong. The company posted record quarterly revenue of $962.0 million, a 33% year-over-year increase, and adjusted earnings per share of $0.24, which exceeded the Zacks Consensus Estimate of $0.20. Adjusted net income rose 44% to $24.4 million, and adjusted EBITDA climbed 5% to $75.7 million. Management also raised full-year 2026 guidance, now projecting revenue of $3.59 billion to $3.79 billion and adjusted EBITDA of $285 million to $310 million, incorporating contributions from the recently closed acquisition of JJ White.

Yet beneath the headline beats, profitability metrics told a more troubling story. Base gross profit margin contracted from 8.9% in Q2 2025 to 7.9% in Q2 2026 — a 100-basis-point decline. Management attributed roughly 95 basis points of that compression to two factors: an estimated $6 million headwind from elevated fuel prices tied to Middle East conflicts, and approximately $3 million in workforce mobilization and ramp-up costs as the company expanded U.S. Gas segment headcount by about 1,700 employees, or 18%, during the first half of 2026. GAAP net income attributable to common stock fell to $6.1 million from $8.1 million a year earlier, further underscoring the bottom-line pressure.

Chicago Write-Down and One-Time Charges

Compounding the margin story, Centuri recorded a $9.0 million revenue reversal related to legacy accounts receivable and contract assets from pre-2020 City of Chicago work. The write-down followed an April 2026 opinion and order by the Circuit Court of Cook County, Illinois, and reduced second-quarter U.S. Gas segment revenue accordingly. While the company excluded this item from its non-GAAP adjusted results, the charge served as a reminder of lingering legacy liabilities and contributed to the gap between GAAP and adjusted profitability that some investors found difficult to overlook.

Analyst Reaction and Historical Pattern

JPMorgan responded to the report by trimming its price target on CTRI to $26 from $29, adding to the selling pressure. The downgrade reflected caution around the timeline for margin recovery, even as the firm acknowledged the company's strong commercial momentum. Notably, Tuesday's sell-off mirrors the stock's reaction to first-quarter 2026 results, when CTRI fell approximately 19.6% in a single session despite beating estimates. This pattern suggests that elevated expectations — and perhaps confusion around varying consensus figures — have set a high bar that the company has struggled to clear in the eyes of the market.

Market Context and Trading Activity

The decline in CTRI shares was accompanied by heavy trading volume, far exceeding the average daily turnover seen in recent sessions. The move pushed the stock near its 52-week low of $19.04, a stark contrast to its 52-week high of $42.99. The sell-off occurred against a relatively stable broader market backdrop, indicating that the price action was company-specific rather than sector- or macro-driven. The utilities and infrastructure services sector did not exhibit a comparable downdraft, reinforcing the view that Centuri's margin narrative — not industry headwinds — drove the retreat.

What Comes Next for CTRI

Looking ahead, Centuri management expressed confidence that second-half 2026 gross profit margins would improve significantly, forecasting approximately 9.0% base gross profit margin with the third quarter expected to be the strongest period due to favorable seasonal weather patterns. The JJ White acquisition, closed on July 20, 2026, is expected to contribute more than $20 million in annual gross profit and be immediately accretive to adjusted net income. The company's $6.4 billion backlog and $16 billion opportunity pipeline provide substantial revenue visibility. However, risks remain: fuel cost volatility, successful integration of JJ White, execution on workforce scaling, and the inherently unpredictable nature of storm restoration services all represent variables that could influence whether Centuri can deliver the margin expansion it has promised through 2029.

Trending AI Robots

In volatile market environments like the one impacting CTRI today, traders increasingly turn to automated strategies for disciplined decision-making. Tickeron's Trending AI Robots page showcases a curated selection of hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured. These bots vary by strategy, timeframe, performance metrics, and traded symbols, offering users a diverse menu of approaches. Whether you seek short-term tactical signals or longer-term trend-following models, exploring the Trending AI Robots section may help you identify data-driven strategies aligned with today's market dynamics.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CTRI

CTRI in +3.80% Uptrend, growing for three consecutive days on August 03, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CTRI advanced for three days, in of 140 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for CTRI's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

CTRI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 27 cases where CTRI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CTRI as a result. In of 48 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CTRI turned negative on August 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 19 similar instances when the indicator turned negative. In of the 19 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTRI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CTRI entered a downward trend on August 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CTRI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.542) is normal, around the industry mean (4.361). CTRI's P/E Ratio (66.303) is considerably higher than the industry average of (21.396). CTRI's Projected Growth (PEG Ratio) (1.007) is very low in comparison to the industry average of (2.263). CTRI's Dividend Yield (0.000) is considerably lower than the industry average of (0.036). CTRI's P/S Ratio (0.622) is slightly lower than the industry average of (2.170).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTRI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 59, placing this stock worse than average.

Industry description

Gas distributors are involved in moving and selling gas – from wellheads or over-distribution systems operated by other firms – to residential and non-residential customers. These companies perform tasks such as the gathering and processing of gas, intrastate and interstate transport, and delivery to the customer. Some of the biggest gas distributing companies in the U.S. include Sempra Energy, Avangrid Inc and Atmos Energy Corporation.

Market Cap

The average market capitalization across the Gas Distributors Industry is 6.46B. The market cap for tickers in the group ranges from 13.65M to 29.88B. GASNY holds the highest valuation in this group at 29.88B. The lowest valued company is CGFEF at 13.65M.

High and low price notable news

The average weekly price growth across all stocks in the Gas Distributors Industry was -3%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was -1%. OPAL experienced the highest price growth at 8%, while CTRI experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the Gas Distributors Industry was 96%. For the same stocks of the Industry, the average monthly volume growth was 55% and the average quarterly volume growth was 33%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 41
P/E Growth Rating: 57
Price Growth Rating: 53
SMR Rating: 71
Profit Risk Rating: 58
Seasonality Score: -39 (-100 ... +100)
View a ticker or compare two or three
CTRI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry GasDistributors

Profile
Details
Industry
N/A
Address
19820 North 7th Avenue
Phone
+1 623 582-1235
Employees
12500
Web
https://www.centuri.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.